Artificial intelligence (AI) technologies to assist histopathology for prostate cancer diagnosis [ID6684]

Status:

In progress

Technology type:

Device

Decision:

Prioritised

Prioritisation programme:

HealthTech

Reason for decision:

Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in use addressed, and help them make the best use of NHS resources

Rationale:

Prioritisation Board agreed that this appears to be a promising technology which has the potential to improve the efficiency of pathology services for this indication. They agreed that the topic should be prioritised

Process:

STA Standard

Provisional Schedule

Committee meeting:

18 November 2026

Expected publication:

21 April 2027

Timeline

Key events during the development of the guidance:

For further information on our processes and methods, please see our CHTE processes and methods manual